Search results
Found 2 matches for
Professor Udo Oppermann, Director of Laboratory Sciences at NDORMS, is the Scientific Director for Oxford in a new alliance between the University of Oxford and Bayer Healthcare. This strategic research alliance in the area of gynaecological therapies is for an initial period of two years, but is open for extension to up to five years.
Patient and public involvement in Rheumatology research – embracing the wave of change
Main PPI
28 July 2021
On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.
Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints
Main PPI
5 March 2021
Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.